Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in YARW — Yarrow Bioscience, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to YARW Full portfolio

Position in YARW

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$42
+$4 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 44 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in YARW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. YARW ranks #396 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in YARW

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42 65
2026-03-31 $38 65
2025-12-31 $37 65
2025-09-30 $21 65
2025-06-30 $107 65
2025-03-31 $102 65
2024-12-31 $217 65
2024-09-30 $122 65
2024-06-30 $128 65
2024-03-31 $533 174
2023-12-31 $400 172
2023-09-30 $423 105
2023-06-30 $364 89
2023-03-31 $267 87